Zytiga Europska Unija - hrvatski - EMA (European Medicines Agency)

zytiga

janssen-cilag international n.v. - abirateron acetat - prostatske neoplazme - endokrinska terapija - zytiga je navedena s преднизоном ili преднизолоном za liječenje метастатического kastracija otporan raka prostate kod odraslih muškaraca asimptomatska ili slabo simptomi nakon neuspjeha androgen-депривационной terapije kod kojih je kemoterapija nije klinički indicatedthe obrade metastatic кастраци-aksijalni rak prostate kod odraslih muškaraca, čija je bolest napredovala nakon kemoterapije na temelju доцетаксела način.

Rezolsta Europska Unija - hrvatski - EMA (European Medicines Agency)

rezolsta

janssen-cilag international n.v. - дарунавир, кобицистат - hiv infekcije - antivirals for systemic use, antivirals for treatment of hiv infections, combinations - rezolsta, indicirana je u kombinaciji s drugim antiretrovirusnim lijekovima za liječenje infekcije virusom humane imunodeficijencije 1 (hiv 1) u odraslih osoba starijih od 18 godina. Генотипическое testiranje trebali bi se rukovoditi pri korištenju rezolsta.

Abiraterone Accord Europska Unija - hrvatski - EMA (European Medicines Agency)

abiraterone accord

accord healthcare s.l.u. - abirateron acetat - prostatske neoplazme - endokrinska terapija - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Abiraterone Mylan Europska Unija - hrvatski - EMA (European Medicines Agency)

abiraterone mylan

mylan ireland limited - abirateron acetat - prostatske neoplazme - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Abiraterone Krka Europska Unija - hrvatski - EMA (European Medicines Agency)

abiraterone krka

krka, d.d., novo mesto - abirateron acetat - prostatske neoplazme - endokrinska terapija - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Instanyl Europska Unija - hrvatski - EMA (European Medicines Agency)

instanyl

takeda pharma a/s - fentanil citrat - pain; cancer - analgetici - instanyl je indiciran za upravljanje probavnom boli kod odraslih koji već primaju opioidnu terapiju za kroničnu bol u raku. probijanje boli je prolazno pogoršanje boli koja se javlja na pozadini drugačije kontrolirane upornosti boli.  patients receiving maintenance opioid therapy are those who are taking at least 60 mg of oral morphine daily, at least 25 micrograms of transdermal fentanyl per hour, at least 30 mg oxycodone daily, at least 8 mg of oral hydromorphone daily or an equianalgesic dose of another opioid for a week or longer.

Vorikonazol Pliva 200 mg prašak za otopinu za infuziju Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

vorikonazol pliva 200 mg prašak za otopinu za infuziju

pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb, hrvatska - vorikonazol - prašak za otopinu za infuziju - 200 mg - urbroj: jedna bočica sadrži 200 mg vorikonazola

Brieka 100 mg tvrde kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

brieka 100 mg tvrde kapsule

actavis group ptc ehf, reykjavikurvegur 76-78, hafnarfjordur, island - pregabalinum - kapsula, tvrda - 100 mg - urbroj: svaka tvrda kapsula sadrži 100 mg pregabalina

Brieka 150 mg tvrde kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

brieka 150 mg tvrde kapsule

actavis group ptc ehf, reykjavikurvegur 76-78, hafnarfjordur, island - pregabalinum - kapsula, tvrda - 150 mg - urbroj: svaka tvrda kapsula sadrži 150 mg pregabalina

Brieka 200 mg tvrde kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

brieka 200 mg tvrde kapsule

actavis group ptc ehf, reykjavikurvegur 76-78, hafnarfjordur, island - pregabalinum - kapsula, tvrda - 200 mg - urbroj: svaka tvrda kapsula sadrži 200 mg pregabalina